Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1972 Dec;46(4):753–763. doi: 10.1111/j.1476-5381.1972.tb06900.x

The ring test

A quantitative method for assessing the `cataleptic' effect of cannabis in Mice

R G Pertwee
PMCID: PMC1666359  PMID: 4655271

Abstract

1. A bioassay for cannabis, called the ring test, has been developed in which the percentage of the total time spent on a horizontal wire ring during which a mouse remains completely immobile is recorded.

2. The effect of cannabis on mobility is a dose-related, graded response.

3. Threshold doses of cannabis extract are 12·5 mg/kg when injected intravenously, and 100 mg/kg when injected intraperitoneally or subcutaneously.

4. The method provides a measure of the `cataleptic' effect of cannabis. Chlorpromazine in doses of 1 mg/kg upwards also produces the effect but barbitone does not.

5. It is concluded that Δ1-tetrahydrocannabinol (Δ1-THC) is largely responsible for the effect of cannabis extract on mobility; the potency ratio of Δ1-THC to cannabis extract is between 10 and 20. Δ1-Tetrahydrocannabidivarol (Δ1-THD) also affects mobility but is less active than Δ1-THC. Cannabidiol has no effect when injected intraperitoneally in doses up to 100 mg/kg.

Full text

PDF
753

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlini E. A., Hamaoui A., Bieniek D., Korte F. Effects of (--) delta-9-trans-tetrahydrocannabinol and a synthetic derivative on maze performance of rats. Pharmacology. 1970;4(6):359–368. doi: 10.1159/000136165. [DOI] [PubMed] [Google Scholar]
  2. Carlini E. A., Santos M., Claussen U., Bieniek D., Korte F. Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa. Psychopharmacologia. 1970 Aug 19;18(1):82–93. doi: 10.1007/BF00402387. [DOI] [PubMed] [Google Scholar]
  3. Christensen H. D., Freudenthal R. I., Gidley J. T., Rosenfeld R., Boegli G., Testino L., Brine D. R., Pitt C. G., Wall M. E. Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse. Science. 1971 Apr 9;172(3979):165–167. doi: 10.1126/science.172.3979.165. [DOI] [PubMed] [Google Scholar]
  4. Dewey W. L., Harris L. S., Howes J. F., Kennedy J. S., Granchelli F. E., Pars H. G., Razdan R. K. Pharmacology of some marijuana constituents and 2 heterocyclic analogues. Nature. 1970 Jun 27;226(5252):1265–1267. doi: 10.1038/2261265a0. [DOI] [PubMed] [Google Scholar]
  5. Garriott J. C., King L. J., Forney R. B., Hughes F. W. Effects of some tetrahydrocannabinols on hexobarbital sleeping time and amphetamine induced hyperactivity in mice. Life Sci. 1967 Oct 1;6(19):2119–2128. doi: 10.1016/0024-3205(67)90232-9. [DOI] [PubMed] [Google Scholar]
  6. Gill E. W., Paton W. D., Pertwee R. G. Preliminary experiments on the chemistry and pharmacology of cannabis. Nature. 1970 Oct 10;228(5267):134–136. doi: 10.1038/228134a0. [DOI] [PubMed] [Google Scholar]
  7. Grunfeld Y., Edery H. Psychopharmacological activity of the active constituents of hashish and some related cannabinoids. Psychopharmacologia. 1969;14(3):200–210. doi: 10.1007/BF00404218. [DOI] [PubMed] [Google Scholar]
  8. Holtzman D., Lovell R. A., Jaffe J. H., Freedman D. X. 1-delta9-tetrahydrocannabinol: neurochemical and behavioral effects in the mouse. Science. 1969 Mar 28;163(3874):1464–1467. doi: 10.1126/science.163.3874.1464. [DOI] [PubMed] [Google Scholar]
  9. Jones G., Pertwee R. G. A metabolic interaction in vivo between cannabidiol and 1 -tetrahydrocannabinol. Br J Pharmacol. 1972 Jun;45(2):375–377. doi: 10.1111/j.1476-5381.1972.tb08092.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Paton W. D., Pertwee R. G. Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism. Br J Pharmacol. 1972 Feb;44(2):250–261. [PMC free article] [PubMed] [Google Scholar]
  11. Scheckel C. L., Boff E., Dahlen P., Smart T. Behavioral effects in monkeys of racemates of two biologically active marijuana constituents. Science. 1968 Jun 28;160(3835):1467–1469. doi: 10.1126/science.160.3835.1467. [DOI] [PubMed] [Google Scholar]
  12. Welch B. L., Welch A. S., Messiha F. S., Berger H. J. Rapid depletion of adrenal epinephrine and elevation of telencephalic serotonin by (-)-trans- 9 -tetrahydrocannabinol in mice. Res Commun Chem Pathol Pharmacol. 1971 May;2(3):382–391. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES